lyophilized peptides
A defined research blend containing retatrutide 20mg and tirzepatide 40mg for controlled comparative receptor-signalling, analytical compatibility, and formulation studies.
Core identifiers are presented in a concise technical format so research teams and distributors can evaluate the material quickly and request batch-specific documentation when needed.
RTT60 combines retatrutide and tirzepatide at a defined nominal mass ratio. The blend is intended for controlled in-vitro comparison, analytical characterisation, and component compatibility workflows.
The blend contains two independent peptide components and therefore has no single molecular formula or molecular weight.
Analytical documentation is organized around purity, identity, and batch traceability. Availability is confirmed for the specific specification and batch requested.
Chromatographic purity results are documented against the applicable batch specification.
Mass spectrometry support is available for molecular identity verification.
Certificate details can be provided for review before or with a qualified order.
Choose the required research specification when requesting availability, documentation, and a quotation.
Send the required specification and quantity. Our team will confirm current availability, documentation, and packaging options.
